Pituitary Neuroendocrine Tumor of PIT1-Lineage

Pituitary Neuroendocrine Tumor of PIT1-Lineage — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03457389	Comparison of Treatment Outcome of Cabergoline According to Target Prolactin Levels in Patients With Prolactinoma	unknown	N/A	68	Seoul National University HospitalOTHER	1	Mar 18, 2020	clinicaltrials
NCT03717454	Dopamine D2 Receptors(D2R) Imaging in Prolactinomas	unknown	N/A	50	Zhebao WuOTHER	0	Nov 20, 2018	clinicaltrials
NCT03400865	Cabergoline Combined Hydroxychloroquine/Chloroquine to Treat Resistant Prolactinomas	unknown	N/A	30	Zhebao WuOTHER	1	Oct 16, 2018	clinicaltrials
NCT03353025	Study on Therapy of Non-invasive Prolactinoma(TNAPA)

Data updated 22 days agoSource updated Mar 18, 2020source: clinicaltrials